Open AccessSpecific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
Author(s) -
Hao Sun,
SiYang Maggie Liu,
Jiaying Zhou,
Jintian Xu,
Huang-Kai Zhang,
HongHong Yan,
Jiaojiao Huan,
Pingping Dai,
ChongRui Xu,
Jian Su,
Yanfang Guan,
Xin Yi,
Rongshan Yu,
WenZhao Zhong,
YiLong Wu
Publication year - 2020
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2020.102990
Subject(s) - missense mutation , kras , nonsense mutation , adenocarcinoma , cancer research , biology , immune checkpoint , lung cancer , immune system , immunotherapy , mutation , gene , cancer , immunology , genetics , medicine , oncology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom